Tradestie Institutional Equity Comparison Engine
RXD vs SSG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RXD Overall Edge
RXD Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares UltraShort Health Care (RXD) driven by superior Options & Structure while SSG counters with relative strength in Momentum & Technical. Fundamentally, RXD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SSG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RXD sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against SSG sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
RXD N/M vs SSG N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
SSG
1Y +26.9% vs +112.6% ยท 52W Pos 29% vs 32%
Options & Structure Winner
RXD
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (50th %ile IV)
RXD
NYSE Arca
ProShares UltraShort Health Care
Institutional Equity
$11.95
+1.01% 1D
Market Cap
N/A
1M Return
-11.84%
1Y Return
+26.9%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 80.0
Fund 66.0
Flow 50.0
Mom 68.9
SSG
NYSE Arca
ProShares UltraShort Semiconductors
Institutional Equity
$17.50
+9.51% 1D
Market Cap
N/A
1M Return
+36.19%
1Y Return
+112.64%
Forward P/E
N/M
Unified AI Score
34.6 / 100
SELL
Tech 50.0
Fund 31.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RXD +26.9%
SSG +112.64%
Spread: +85.74 pp (SSG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RXD TTM Op. Margin: N/A
SSG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RXD vs SSG. Trailing 12-month operating profitability (RXD N/A vs SSG N/A) and valuation multiples (RXD N/M vs SSG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RXD | SSG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 29% ($8โ$21) | 32% ($8โ$38) | Stronger Trend | SSG |
| Beta / 30D Volatility Risk Regime | -0.21ฮฒ ยท 40% Vol | -4.74ฮฒ ยท 125% Vol | Lower Realized Risk | RXD |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 34.6 / 100 (SELL) | Higher Composite | RXD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RXD vs SSG Buy Guide
RXD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
SSG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RXD nor SSG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.